首页> 外国专利> 4-Guanidino:methyl cyclohexane carboxylate derivs. - inhibit serine protease(s), such as trypsin, chymotrypsin, thrombin, urokinase, plasmin and kallikrein, and are antiallergics

4-Guanidino:methyl cyclohexane carboxylate derivs. - inhibit serine protease(s), such as trypsin, chymotrypsin, thrombin, urokinase, plasmin and kallikrein, and are antiallergics

机译:4-胍基基氨基甲酸甲酯:环己基羧酸甲酯。 -抑制丝氨酸蛋白酶,例如胰蛋白酶,胰凝乳蛋白酶,凝血酶,尿激酶,纤溶酶和激肽释放酶,并且是抗过敏药

摘要

4-Guanidinomethyl- cyclohexane carboxylates of formula (I) and their salts are new (where R1 is indanyl, indolyl, quinolyl, chromonyl, R2-substd. naphthyl or R3, R4, R5-substd. phenyl; R2 is halo or nitro; R3 is halo, alkyl, nitro, cyano, acetamido, sulphamoyl, benzoyl, phenoxy or trifluoromethyl and R4, R5 independently are H, halo or alkyl). (I) inhibit serine proteases and are anti-allergics. Serine proteases include trypsin, chymotrypsin, thrombin, plasmin, kallikrein and urokinase. (I) inhibit the liberation of histamine, prevent anaphylactic shock and experimental asthma in guinea pigs. (I) have low toxicity (oral LD50 of (I)/R1 is 4-tert-butylphenyl as the hydrochloride of the trans isomer) is 5400-73000 mg/kg in mice and 10800-11000 mg/kg in rats) and are administered parenterally or orally (daily doses of 30-900 mg).
机译:式(I)的4-胍基甲基-环己烷羧酸盐及其盐是新的(其中R1为茚满基,吲哚基,喹啉基,苯二甲酰基,R2-取代萘基或R3,R4,R5-取代苯基; R2为卤素或硝基; R 3为卤素,烷基,硝基,氰基,乙酰胺基,氨磺酰基,苯甲酰基,苯氧基或三氟甲基,并且R 4,R 5独立地为H,卤素或烷基。 (I)抑制丝氨酸蛋白酶并且是抗过敏剂。丝氨酸蛋白酶包括胰蛋白酶,胰凝乳蛋白酶,凝血酶,纤溶酶,激肽释放酶和尿激酶。 (I)抑制组胺的释放,预防过敏性休克和豚鼠的实验性哮喘。 (I)毒性低((I)/ R1的口服LD50为4-叔丁基苯基,为反式异构体的盐酸盐),在小鼠中为5400-73000 mg / kg,在大鼠中为10800-11000 mg / kg),并且肠胃外或口服给药(每日剂量为30-900 mg)。

著录项

  • 公开/公告号ES8406189A1

    专利类型

  • 公开/公告日1984-08-01

    原文格式PDF

  • 申请/专利权人 NIPPON CHEMIPHAR CO. LTD.;

    申请/专利号ES19820508731

  • 发明设计人

    申请日1982-01-14

  • 分类号A61K31/15;

  • 国家 ES

  • 入库时间 2022-08-22 09:05:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号